Data Technology + RWD Are Positive for Rare Disease Treatment

Technology that offers tools that conform, de-identify, link and aggregate data and data science tools like AI, machine learning and advanced analytics, can help those researching rare diseases overcome the hurdles they face in discovery and development.  The post Data Technology + RWD Are Positive for Rare Disease Treatment appeared first on MedCity News.

Read More

20% of the economy will be spent on health care by 2033

CMS’s Office of the Actuary predicts that national healthcare expenditures (NHE) will increase from 17.6% of GDP in 2023 to 20.3% of GDP by 2033. The Keehan et al. (2025) paper provides more details: National health expenditures are projected to have grown 8.2 percent in 2024 and to increase 7.1 percent in 2025, reflecting continued…

Read More

Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in Funding

Vor Bio is licensing global rights a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last month ceased its cancer R&D and announced it would explore strategic alternatives. The post Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3…

Read More